$5.97
7.76% today
Nasdaq, Apr 02, 10:17 pm CET
ISIN
CA60255C1095
Symbol
MNMD
Sector
Industry

Mind Medicine Inc - Ordinary Shares (Sub Voting) Stock price

$5.97
-0.10 1.65% 1M
+0.42 7.57% 6M
-0.99 14.22% YTD
-3.88 39.39% 1Y
-10.83 64.46% 3Y
-0.62 9.46% 5Y
-20.97 77.84% 10Y
Nasdaq, Closing price Wed, Apr 02 2025
+0.43 7.76%
ISIN
CA60255C1095
Symbol
MNMD
Sector
Industry

Key metrics

Market capitalization $217.98m
Enterprise Value $-33.91m
P/E (TTM) P/E ratio negative
EV/FCF (TTM) EV/FCF 0.44
P/B ratio (TTM) P/B ratio 2.81
Revenue (TTM) Revenue $0.00
EBIT (operating result TTM) EBIT $-103.92m
Free Cash Flow (TTM) Free Cash Flow $-77.52m
Cash position $273.74m
EPS (TTM) EPS $-1.91
P/E forward negative
Short interest 15.10%
Show more

Is Mind Medicine Inc - Ordinary Shares (Sub Voting) a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,807 stocks worldwide.

Mind Medicine Inc - Ordinary Shares (Sub Voting) Stock Analysis

Unlock Scores for Free

Analyst Opinions

11 Analysts have issued a Mind Medicine Inc - Ordinary Shares (Sub Voting) forecast:

11x Buy
100%

Analyst Opinions

11 Analysts have issued a Mind Medicine Inc - Ordinary Shares (Sub Voting) forecast:

Buy
100%

Financial data from Mind Medicine Inc - Ordinary Shares (Sub Voting)

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Dec '24
+/-
%
- -
-
100%
- Direct Costs 0.53 0.53
83% 83%
-
-0.53 -0.53
83% 83%
-
- Selling and Administrative Expenses 38 38
1% 1%
-
- Research and Development Expense 65 65
32% 32%
-
-103 -103
14% 14%
-
- Depreciation and Amortization 0.53 0.53
83% 83%
-
EBIT (Operating Income) EBIT -104 -104
11% 11%
-
Net Profit -109 -109
14% 14%
-

In millions USD.

Don't miss a Thing! We will send you all news about Mind Medicine Inc - Ordinary Shares (Sub Voting) directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Mind Medicine Inc - Ordinary Shares (Sub Voting) Stock News

Neutral
Business Wire
9 days ago
NEW YORK--(BUSINESS WIRE)--Mind Medicine (MindMed) Inc. (NASDAQ: MNMD) (the “Company” or “MindMed”), a late-stage clinical biopharmaceutical company developing novel product candidates to treat brain health disorders, today announced the issuance of inducement grants to four newly hired non-executive employees consisting of options to purchase an aggregate of 88,950 common shares of the Company...
Neutral
Business Wire
16 days ago
NEW YORK--(BUSINESS WIRE)--Mind Medicine (MindMed) Inc. (NASDAQ: MNMD), (the "Company" or "MindMed"), a late-stage clinical biopharmaceutical company developing novel product candidates to treat brain health disorders, today announced the appointment of Matt Wiley as its Chief Commercial Officer (CCO). In his new role, Mr. Wiley will serve as a member of the executive team, overseeing the Compa...
Neutral
Seeking Alpha
27 days ago
Mind Medicine (MindMed) Inc. (NASDAQ:MNMD ) Q4 2024 Earnings Conference Call March 6, 2025 8:00 AM ET Company Participants Stephanie Fagan - Chief Corporate Affairs Officer Rob Barrow - CEO Dan Karlin - CMO Conference Call Participants Madhu Yennawar - Leerink Gavin Clark-Gartner - Evercore ISI Charles Duncan - Cantor Joel Beatty - Baird Rudy Li - Chardan Sumant Kulkarni - Canaccord Genuity Pat...
More Mind Medicine Inc - Ordinary Shares (Sub Voting) News

Company Profile

Mind Medicine (MindMed), Inc. operates as a neuro-pharmaceutical company that discovers, develops and deploys psychedelic medicines to improve health, promote wellness and alleviate suffering. The firm develops a non-hallucinogenic version of the psychedelic ibogaine. The company was founded by Stephen L. Hurst, Scott M. Freeman, Leonard Latchman and Jamon Alexander Rahn in 2019 and is headquarter in New York, NY.

Head office Canada
CEO Robert Barrow
Employees 74
Founded 2019
Website www.mindmed.co

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today